TrialNature medicine2022

Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial.

Dalong Zhu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.